BeOne Medicines (ONC) EBT Margin Growth (3y) (2018 - 2026)
BeOne Medicines (ONC) EBT Margin Growth (3y) (2018 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBT Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
49,756.00 |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
441.00 |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
- |
| 10 |
BeOne Medicines |
- |
- |
1.35 Bn |
9,237.00 |
| Date | Value |
| Mar 31, 2026 |
9,237.00 |
| Dec 31, 2025 |
12,335.00 |
| Sep 30, 2025 |
15,263.00 |
| Jun 30, 2025 |
17,081.00 |
| Mar 31, 2025 |
13,925.00 |
| Dec 31, 2024 |
27,565.00 |
| Sep 30, 2024 |
19,997.00 |
| Jun 30, 2024 |
30,900.00 |
| Mar 31, 2024 |
-4,260.00 |
| Dec 31, 2023 |
42,620.00 |
| Sep 30, 2023 |
50,700.00 |
| Jun 30, 2023 |
45,292.00 |
| Mar 31, 2023 |
62,278.00 |
| Dec 31, 2022 |
55,514.00 |
| Sep 30, 2022 |
47,979.00 |
| Jun 30, 2022 |
-10,736.00 |
| Mar 31, 2022 |
7,789.00 |
| Dec 31, 2021 |
18,594.00 |
| Sep 30, 2021 |
5,767.00 |
| Jun 30, 2021 |
-1,534.00 |